Assets
Cash equivalents:
$ 34,881
Investments in securities:
$ 130,550,093
Dividends and interest receivable:
$ 421,470
Other assets:
$ 41,810
Total Assets = $ 131,048,254
Liabilities and Net Assets
Grants approved for future payment:
$ 5,022,254
Accounts payable and accrued expenses:
$ 129,061
Deferred excise taxes:
$ 12,695
Total liabilities:
$ 5,164,010
Net assets:
$125,884,244
Total Liabilities and Net Assets = $ 131,048,254
Statements of Activities
Gain (loss) from investments:
$ 20,666,631
Investment related and other expenses:
$ (610,581)
Net gain (loss) from investments:
$ 20,056,050
Grants approved:
$ 6,251,420
Grant support:
$ 936,722
Total grants approved / related expenses:
$ 7,188,142
Net Gain (Loss) for the period = $ 12,867,908